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T
ranscriptional disturbance is implicated in the 
  pathology of polyglutamine diseases, including 
Huntington’s disease (HD). However, it is unknown 
whether transcriptional repression leads to neuronal death 
or what forms that death might take. We found transcrip-
tional repression-induced atypical death (TRIAD) of neu-
rons to be distinct from apoptosis, necrosis, or autophagy. 
The progression of TRIAD was extremely slow in compari-
son with other types of cell death. Gene expression proﬁ  l-
ing revealed the reduction of full-length yes-associated 
protein (YAP), a p73 cofactor to promote apoptosis, as 
speciﬁ  c to TRIAD. Furthermore, novel neuron-speciﬁ  c YAP 
isoforms (YAP∆Cs) were sustained during TRIAD to sup-
press neuronal death in a dominant-negative fashion. 
YAP∆Cs and activated p73 were colocalized in the striatal 
neurons of HD patients and mutant huntingtin (htt) trans-
genic mice. YAP∆Cs also markedly attenuated Htt-induced 
neuronal death in primary neuron and Drosophila mela-
nogaster models. Collectively, transcriptional repression 
induces a novel prototype of neuronal death associated 
with the changes of YAP isoforms and p73, which might 
be relevant to the HD pathology.
Introduction
Neurodegenerative disorders are characterized by the slow exac-
erbation of symptoms and by gradual progression of brain pa-
thologies. Patients suffer for 5–20 yr from the onset of the 
disease to the bed-ridden state. Even fast-progressing amyo-
trophic lateral sclerosis takes 2–5 yr to render the patient bed 
ridden. Regarding the pathology, the total number of neurons 
and neural networks among them decrease. However, some of 
the neurons survive for an extensive period of time despite their 
expression of abnormal structures that are derived principally 
from the pathogenic disease-causing products. Typically, nigral 
neurons that express Lewy bodies in Parkinson’s disease, hippo-
campal neurons that carry paired helical fi  laments in Alzhei-
mer’s disease, and motor neurons bearing Bunina bodies in 
amyotrophic lateral sclerosis can partially survive until the death 
of the patient. The mutant protein aggregates that characterize 
many of these diseases are known to trigger multiple   cellular 
  responses, including ER stress and mitochondrial abnormality. 
These stress responses are clearly suffi  cient to induce apoptosis 
in nonneuronal cell lines, whereas the brain pathology of pa-
tients indicates that neurons survive for a long period before 
their demise. A lengthy period of cell death is also observed in 
the polyglutamine (polyQ) diseases, a major group of neurode-
generation that includes nine disorders (for reviews see Gusella 
and MacDonald, 2000; Zoghbi and Orr, 2000; Ross, 2002; 
  Taylor et al., 2002; Bates, 2003). Again, a fraction of the neurons 
that possess nuclear and/or cytoplasmic inclusions of mutant 
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polyQ peptides survives even in affected regions of the brain un-
til the time of necropsy. So far, there is no model that fully 
explains the lengthy period of cell death in neurodegeneration.
In addition to ER and mitochondrial stresses, transcrip-
tional dysfunction is suggested as a critical pathological compo-
nent of polyQ diseases (for reviews see Gusella and MacDonald, 
2000; Zoghbi and Orr, 2000; Ross, 2002; Taylor et al., 2002; 
Bates, 2003). Translocation of mutant proteins to the nucleus 
seems essential for neuronal dysfunction or cell death in polyQ 
diseases (Klement et al., 1998; Saudou et al., 1998; Katsuno 
et al., 2003). Numerous transcription-related factors, including 
LANP, PQBP-1, N-CoR, ARA24, p53, mSin3A, ETO/MTG8, 
Figure 1.  Transcriptional repression by 𝗂-AMA induces a slowly progressive death of primary neurons. (A) Uptake of BrdU in primary cortical (CTX) or 
cerebellar (CBL) neurons (Hoshino et al., 2004) was remarkably reduced at 6 h after the addition of 25 μg/ml AMA, indicating that AMA reduces tran-
scription. (B) BrdU uptakes per neuronal nucleus at different concentrations of AMA (10 and 250 μg/ml) were analyzed chronologically. Signal intensities 
(AU, arbitrary unit) calculated with A  Q  U  A  C  O  S  M  O  S   (Hamamatsu) were obtained from >500 cells. Means ± SD are shown (error bars). Asterisks indicate 
signiﬁ  cant reductions compared with 0 h (P < 0.01, t test). (C) Survival curves of HeLa cells and primary neurons (cortical, cerebellar, and striatal [STR] 
neurons) with AMA (10, 25, and 250 μg/ml). Viability (percent) indicates live cells/total cells by trypan blue assay (Tagawa et al., 2004) in six indepen-
dent wells. Viability was shown as means ± SD of nonstained cells. Viability of HeLa cells declined at 24 h. In primary neurons, a signiﬁ  cant reduction was 
ﬁ  rst observed at 72 h at all concentrations of AMA. Of the three types of neuron tested, striatal neurons were the most vulnerable to AMA treatment for 
48 h at 25 and 250 μg/ml AMA. P < 0.05 (t test).NEURON DEATH BY TRANSCRIPTIONAL REPRESSION • HOSHINO ET AL.  591
P160/GRIP1, A2BP1, TAFII130, CA150, CRX, Sp1, CtBP, 
PML, TAFII30, NF-κB, and SC35, are known to interact or co-
localize with mutant polyQ disease proteins (for reviews see 
Okazawa, 2003; Sugars and Rubinsztein, 2003). Interaction 
with polyQ proteins may impair physiological functions of these 
transcription factors (Okazawa, 2003; Sugars and Rubinsztein, 
2003), and, fi  nally, even the general transcription level could be 
repressed (Hoshino et al., 2004). Some of these polyQ  pathology-
mediating factors bind directly to the core of transcription ma-
chinery, RNA polymerase II (Pol II; Okazawa et al. 2002). 
Therefore, one of the paramount issues in the fi  eld of polyQ dis-
eases is the relationship between transcriptional dysfunction 
and neuronal death. However, as yet, the role of transcriptional 
disruption in neuronal death is unclear, as is the mode of neuro-
nal death when transcription is severely impaired.
In this study, we found that inhibition of Pol II–dependent 
transcription leads neurons to undergo a slowly progressive atyp-
ical cell death (transcriptional repression-induced atypical death 
[TRIAD]) distinct from apoptosis, necrosis, or autophagy in 
morphological and biochemical analyses. Transcriptome analy-
sis of TRIAD suggested that yes-associated protein (YAP), 
a known transcriptional cofactor, might be relevant to the death 
process. YAP, which was originally found as a binding protein 
to Src homology domain 3 of the yes proto-oncogene product 
(for review see Sudol et al., 1995), acts as a transcriptional cofac-
tor of p73, mediates the expression of cell death–promoting 
genes, and induces apoptosis (Yagi et al., 1999; Basu et al., 2003; 
Melino et al., 2004). We found that in TRIAD, full-length YAP 
(FL-YAP) is down-regulated, and novel neuron-specifi  c YAP∆C 
isoforms lacking the cell death–promoting activity sustain to pro-
tect neurons in a dominant-negative manner. The shift of balance 
in YAP isoforms seemed to slow down the cell death signaling 
pathway of p73 activated by α-amanitin (AMA), at least partially. 
We further questioned the relevance of YAP and p73 to Hunting-
ton’s disease (HD) by using cellular, Drosophila melanogaster, 
and mouse models as well as human brain samples. Our data sug-
gest that these molecules might be involved in neuronal death 
  triggered by mutant Htt, the causative gene product of HD.
Results
Transcriptional repression induces 
an atypical slow neuronal death
To address the role of transcriptional disruption in neuronal 
death, we fi  rst made multiple short inhibitory RNAs (siRNAs) 
against RNA Pol II to suppress Pol II–dependent transcription. 
However, suppression of Pol II was inadequate and reminiscent 
of recent efforts to suppress basic transcription machinery by 
similar approaches (Ni et al., 2004). Therefore, we used a spe-
cifi  c inhibitor of Pol II (AMA) whose three-dimensional molec-
ular structure is exactly complementary to the groove of Pol II, 
through which mRNA is elongated (Cramer et al., 2001; Bush-
nell et al. 2002). Different concentrations of AMA were added 
to the culture medium of HeLa cells, primary rat embryonic 
(embryonic day [E] 15) cortical neurons, rat E15 striatal neu-
rons, and rat pup cerebellar neurons (postnatal day [P] 7). BrdU 
up-take assay (Hoshino et al., 2004) showed signifi  cant repres-
sion of transcription at 6 h of AMA treatment in primary neurons 
(Fig. 1, A and B) and HeLa cells (not depicted). The survival of 
AMA-treated cells estimated by trypan blue assay (Fig. 1 C) 
revealed that AMA induces a slowly progressive cell death in a 
dose-dependent fashion. This was most pronounced in primary 
neurons, with half-lives of nearly 5 d. AMA-induced neuronal 
death was much slower than low potassium–induced apoptosis 
of cerebellar neurons, whose half-life was  12 h (not depicted). 
The slow progression of AMA-induced neuronal death was con-
fi  rmed independently by MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 
5-diphenyltetrazolium bromide) assay (Fig. S1, available at 
http://www.jcb.org/cgi/content/full/jcb.200509132/DC1).
A population of HeLa cells (10–30%) began to show cy-
toplasmic vacuoles proximal to the nucleus (Fig. 2 A, HeLa-
TRIAD) from 6–12 h after the addition of AMA. Similar 
vacuoles were also observed in cortical neurons treated with 
AMA for 2 d (Fig. 2 A, CTX neuron-TRIAD), although with a 
diminished frequency (1–5%). It is important to note that the 
vacuoles did not possess double-membrane structures reminis-
cent of autophagosomes. No classic apoptotic features such as 
chromatin condensation, nuclear fragmentation, or apoptotic 
bodies (Okazawa et al., 1996) were found in these neurons by 
electron microscopic analysis (Fig. 2 A). In addition, no ne-
crotic features such as mitochondrial dilatation (Fig. 2 A, CTX 
neuron necrosis) or cytoplasmic ballooning and rupture (Fig. 
2 A, CTX neuron necrosis) were observed in primary neurons 
under TRIAD.
Immunohistochemical analyses using organelle-  specifi  c 
antibodies excluded the idea that the cytoplasmic vacuole was 
derived from the Golgi apparatus, endosome, lysosome, and 
mitochondria (Fig. S2, available at http://www.jcb.org/cgi/ 
content/full/jcb.200509132/DC1). Autophagosomes induced by 
rapamycin and labeled with EGFP-LC3, a marker protein of the 
autophagosome (Fig. 2 B, top and middle), failed to colocalize 
with AMA-induced vacuoles (Fig. 2 B, bottom). In addition, the 
size of AMA-induced vacuoles was larger than that of autopha-
gosomes (Fig. 2 B, bottom). EGFP-LC3 actually expresses the 
LC3 peptide (Fig. 2 C, arrow), verifying the morphological  result. 
Note that the immunoblot shows a   nonspecifi  c band that is con-
sistently detected by this antibody (Fig. 2 C, asterisk; unpublished 
data). Furthermore, the addition of rapamycin to the medium 
increased LC3-positive vacuoles but did not affect the forma-
tion of LC3-negative vacuoles induced by AMA (Fig. S3 A).
Collectively, these data suggested that AMA-induced cell death 
is distinct from autophagy. Finally, we found colocalization 
of the vacuoles with ECFP-ER fusion constructs (expressing 
calreticulin ER-targeting sequences and KDEL ER retrieval 
tags at the 5′ and 3′ ends, respectively, of ECFP; Fig. 2 D). 
It suggested that vacuoles might be derived from expanded ER.
In agreement with the absence of morphological features 
of apoptosis, genomic DNA analyses of cell lines and primary 
neurons did not show ladder formation after AMA treatment 
(Fig. 3 A). Caspase-3, -7, and -12 were not remarkably activated 
in primary neurons by AMA (Fig. 3 B). AMA induced neither 
the release of cytochrome c into the cytosol from these neurons 
(Fig. 3 C) nor the interaction of annexin-V with the membrane 
of these neurons at an early stage (Fig. S3 B). Caspase  inhibitors JCB • VOLUME 172 • NUMBER 4 • 2006  592
Figure 2.  Morphological features of TRIAD are distinct from those of apoptosis, necrosis, and autophagy. (A) 10–30% of HeLa cells treated with 25 μg/ml 
AMA for 24 h (HeLa-TRIAD) showed cytoplasmic vacuoles (white arrows) proximal to the nucleus (Nucl). Electron microscopic analysis of cortical neurons 
treated with 25 μg/ml AMA for 48 h (CTX neuron TRIAD) revealed similar cytoplasmic vacuoles. Absence of chromatin condensation or nuclear fragmenta-
tion distinguishes TRIAD from classical apoptosis. The normal cytoplasm or mitochondria also excludes typical necrosis (bottom left). Electron microscopic 
analysis of primary cortical neurons in necrosis after freeze-thaw treatment (CTX neuron necrosis) showed the dilation of mitochondria (white arrows) and 
the rupture of cytoplasm (black arrows). Bars, 1 μm. (B) HeLa cells treated with 200 ng/μl rapamycin for 2 h showed autophagy (top and middle). AMA-
induced vacuoles (arrows) did not merge with EGFP-LC3–labeled autophagosomes (bottom). RC, relief contrast. (C) Western blots to verify that pEGFP-LC3 
expresses the LC3 peptide. Both anti-EGFP and anti-LC3 antibodies detect EGFP-LC3 (arrow), conﬁ  rming that the EGFP-LC3 fusion protein is properly ex-
pressed. Asterisk indicates a nonspeciﬁ  c band. (D) A marker protein of ER, ECFP-ER (blue), was localized to AMA-induced vacuoles (arrows), suggesting 
that the vacuoles originate from the ER.NEURON DEATH BY TRANSCRIPTIONAL REPRESSION • HOSHINO ET AL.  593
z-DEVD-fmk and z-VAD-fmk did not repress AMA-induced 
cell death in neurons or in HeLa cells (not depicted). As ex-
pected, cycloheximide did not affect the cell death (not de-
picted). Calpain inhibitors, including ALLN and ALL, showed 
no remarkable effect on cell death. Pretreatment of cells with 
different concentrations of ATP in the medium did not affect 
AMA-induced cell death (not depicted).
Although AMA is a highly specifi  c inhibitor of Pol II, 
as confi  rmed by molecular structural analyses (Cramer et al., 
2001; Bushnell et al. 2002), to further verify that AMA-induced 
cell death is mediated by transcriptional repression, we exam-
ined the effect of another type of transcription inhibitor, actino-
mycin D, on primary neurons (Fig. S4, available at http://www.
jcb.org/cgi/content/full/jcb.200509132/DC1). Actinomycin D 
binds directly to DNA and inhibits transcription (Jones, 1976) 
by stalling the rapidly moving fraction of Pol II (Kimura et al., 
2002). We found that actinomycin D also induced a slowly 
progressive neuronal death (Fig. S4 A), in which some neu-
rons show cytoplasmic vacuoles similar to those by AMA (Fig. 
S4 B). Neither DNA fragmentation nor caspase activation was 
induced by actinomycin D (Fig. S4, C and D). Collectively, 
our results suggest that AMA induces a slowly progressive 
TRIAD of neurons that is distinct from apoptosis, necrosis, 
and autophagy.
Novel YAP isoforms are expressed 
in neurons speciﬁ  cally
To understand the molecular basis of TRIAD, we conducted 
  microarray analysis and compared gene expression profi  les 
  between TRIAD and low potassium–induced apoptosis in pri-
mary neurons. To detect initial changes, neurons were harvested 
at 1 h for RNA preparation. Duplicate experiments allowed us 
to extract eight genes whose expression levels changed in both 
apoptosis and TRIAD and a further 11 genes whose expression 
was changed specifi  cally in TRIAD (Fig. 4 A). The latter group 
included YAP (Fig. 4 B), a transcriptional coactivator of p73 
mediating apoptosis (Basu et al., 2003). Detailed information of 
the selected genes is provided in Fig. S5 (available at http://
www.jcb.org/cgi/content/full/jcb.200509132/DC1). Northern 
blotting confi  rmed that AMA treatment down-regulates YAP 
expression at the level of transcription (Fig. 4 C).
Surprisingly, however, we identifi  ed novel isoforms of 
YAP containing 13-, 25-, and 61-nt inserts (Fig. 4, D and E) in 
addition to the full-length form by PCR cloning with RNA ex-
tracted from nontreated normal cortical and cerebellar neurons. 
The insert sequences matched genomic sequence with consen-
sus junction sequences (Fig. 5). All three insertions lead to a 
reading frame shift, causing truncation of the COOH-terminal 
transcriptional activation domain (Fig. 4, D and E; Yagi et al., 
1999). Therefore, we designated them YAP∆Cs. Tissue expres-
sion profi  ling by RT-PCR revealed that the 13- and 61-nt insert 
isoforms (denoted here as Ins13 and Ins61, respectively) rela-
tively specifi  c to neurons (Fig. 4 F). Brain tissue (Fig. 4 F, third 
lane; not CTX or CBL neurons), including many glial and non-
neuronal cells, showed only faint signals of the 13-nt variant 
comparable with those seen in other tissues (Fig. 4 F). Ins61 
was highly specifi  c to cortical neurons (Fig. 4 F). The 25-nt in-
sert could not be detected by RT-PCR. Supporting the  expression 
Figure 3.  Biochemical features of TRIAD are distinct from 
those of apoptosis. (A) No signiﬁ  cant fragmentation of geno-
mic DNA was observed in TRIAD of P19 cells, HeLa cells, 
primary cerebellar neurons (CBL), and primary cortical neu-
rons (CTX). Genomic DNA was prepared from total (attached 
and ﬂ  oating) cells cultured with 50 μg/ml AMA for 5 d. As 
controls of apoptosis, genomic DNA from P19 cells treated 
with 0.5 μM retinoic acid for 2 d or from cerebellar neurons 
cultured in a low potassium condition for 2 d were used. 
RA, retinoic acid. (B) Caspase-3, -7, and -12 were not re-
markably activated in cortical and cerebellar neurons treated 
with 50 μg/ml AMA. Western blots were performed with an-
tibodies speciﬁ  c for each caspase. F and C, full-length and 
cleaved forms, respectively. (C) No cytochrome c release in 
cytosol was observed in primary neurons treated with AMA. 
Mitochondrial (mito) and cytosol (cyt) fractions were pre-
pared from primary cortical or cerebellar neurons treated 
with 50 μg/ml AMA for 1–5 d and blotted with anticyto-
chrome c antibody.JCB • VOLUME 172 • NUMBER 4 • 2006  594
Figure 4.  Molecular features speciﬁ  c to TRIAD include YAP. (A) Comparison of gene expression proﬁ  les among low potassium–induced apoptosis of cerebel-
lar neurons, TRIAD of cerebellar neurons, and TRIAD of cortical neurons. Three genes were up-regulated, and eight genes were down-regulated speciﬁ  cally in 
TRIAD. (B) Genes speciﬁ  cally changed in TRIAD. (C) Down-regulation of YAP at 1 h after the addition of 25 μg/ml AMA was conﬁ  rmed by Northern blotting. 
The bottom numbers indicate the signal intensities of the bands after correction with the 28S controls. (D) PCR cloning of YAP from primary neurons revealed 
new isoforms lacking the COOH-terminal transactivation domain (YAP∆Cs). The scheme shows structures of YAP∆Cs, mouse/rat fFL-YAP (m/rYAP = human 
YAP2), and human YAP1 (hYAP1). (E) Amino acid sequences of YAP∆Cs around the junction (boxed area of D). Asterisks indicate conserved amino acids in 
four isoforms. (F) RT-PCR analysis of tissue-speciﬁ  c expression of YAP∆C isoforms. In addition to YAP∆Cs, we detected full-length YAP (FL-YAP) and a previ-
ously reported isoform possessing a 48-bp insertion that does not cause a frame shift (ins48). YAP∆Cins25 containing a 25-bp insert was not detected in 
this analysis. M, molecular weight marker. (G) Western blots showing chronological expression of YAP isoforms during TRIAD. In primary cortical neurons 
(CTX), the expression of YAP∆Cs was sustained for 6 d after AMA addition, whereas FL-YAP was repressed within 2 d. Notably, the expression of YAP∆Cs 
was very low in HeLa cells. The asterisk indicates an undetermined band whose expression was correlated with YAP. Vor, before the addition of AMA.NEURON DEATH BY TRANSCRIPTIONAL REPRESSION • HOSHINO ET AL.  595
of YAP∆Cs in neurons, a truncated YAP isoform–specifi  c anti-
body stained cortical and striatal neurons   in immunohistochem-
istry with human and mouse brains (see Figs. 8 and 9).
In addition, temporal regulation of YAP isoforms during 
TRIAD was observed by Western blot analysis. Interestingly, 
although FL-YAP decreased before day 3 in cortical neurons, 
YAP∆Cs were expressed at a relatively constant level (Fig. 4 G). 
It is also important to note that the levels of YAP∆Cs were sig-
nifi  cantly lower in HeLa cells (Fig. 4 G). These data prompted 
us to test the function of YAP isoforms in TRIAD.
YAP isoforms modulate TRIAD
p73 and YAP mediate cisplatin (CDDP)-induced apoptosis of a 
cancer cell line, MCF-7 cells (Basu et al., 2003). In this case, 
DNA damage induced by CDDP leads to activation of p73, and 
the transcription cofactor YAP promotes p73-mediated transac-
tivation of cell death genes, including Bax and possibly PUMA 
(Melino et al., 2004). Truncation of the transcriptional activa-
tion domain (Yagi et al., 1999) in YAP may impede transduction 
of the cell death stimulus, and YAP∆Cs may act as dominant 
negatives against FL-YAP. As expected, luciferase assay showed 
that expression of YAP∆C isoforms represses p73-mediated 
  activation of the p21/WAF1 gene promoter in MCF-7 cells by 
CDDP (Fig. 6 A, left; Basu et al., 2003). Overexpression of FL-
YAP did not promote transcriptional activation any more (Fig. 
6 A) probably because the function of endogenous FL-YAP was 
saturated. YAP∆Cs also showed repressive effects on CDDP-
induced apoptosis of MCF-7 cells (Fig. 6 B) mediated by FL-
YAP (Basu et al., 2003). In these assays, the expression of each 
truncate was confi  rmed in parallel (Fig. 4, A and B; right).
Next, we tested whether YAP∆Cs could repress TRIAD 
of primary cortical neurons (Fig. 6 C). Before the addition of 
AMA, neurons were infected with adenovirus vectors for 
YAP∆Cs or the empty adenovector (AxCA) as a negative con-
trol (Fig. 6 C, left). Expression of YAP∆Cs was confi  rmed by 
Western blot analysis simultaneously (Fig. 6 C, right). To fur-
ther test whether YAP∆Cs are involved in TRIAD, we trans-
fected a siRNA targeting a sequence shared by three YAP∆C 
isoforms but not FL-YAP (Fig. 6 D). The siRNA accelerated 
TRIAD to  90% (Fig. 6 D), supporting the idea that YAP∆Cs 
suppress the cell death process in TRIAD at least partially.
The suppression of TRIAD by YAP∆Cs suggested, in 
turn, that p73, the target transcription factor of FL-YAP, would 
be activated in TRIAD. Therefore, we analyzed the amount and 
phosphorylation of p73 in AMA-treated cortical neurons at 
day 2. As expected, AMA accelerated the phosphorylation of 
p73, whereas the total amount of p73 was not changed (Fig. 
6 E). Together with the former results, YAP∆Cs might inhibit 
the action of p73, leading neurons to apoptosis by antagonizing 
FL-YAP, especially at the early phase of TRIAD when FL-YAP 
is still expressed (Fig. 4 G).
Relevance of YAP isoforms 
and p73 to HD pathology
To investigate the relevance of YAP isoforms to the HD pa-
thology, we infected primary cortical neurons with adenovirus 
vectors of YAP∆Cs and found that expression of the truncated 
isoforms repressed Htt111-induced cell death of cortical neurons 
at 4 d after the infection of adenovirus vectors (Fig. 7 A; Tagawa 
et al., 2004). Consistently, YAP∆C-specifi  c siRNA promoted 
Htt-induced cell death of cortical neurons (Fig. 7 B). We also 
found that mutant Htt induced p73 phosphorylation in cortical 
neurons at 2 d after infection (Fig. 7 C). Suppression of p73 by 
siRNA repressed cell death of mutant Htt-expressing neurons at 
day 4 (Fig. 7 D), suggesting the relevance of p73 to Htt-induced 
neuronal death. To examine the possible   involvement of p73 
Figure 5.  Genomic structures of YAP𝖫C isoforms. 
  Genomic sequence numbers are derived from rat chro-
mosome 8 supercontig. cDNA nucleotide sequences 
of novel YAP isoforms are available from GenBank/
EMBL/DDBJ accession no. DQ186896, DQ186897, 
and DQ186898. Gray and black boxes are exons; 
black boxes indicate exons that were newly identiﬁ  ed 
in this study.JCB • VOLUME 172 • NUMBER 4 • 2006  596
Figure 6.  YAP𝖫C isoforms repress apoptosis and the TRIAD. (A) p73-mediated transcriptional activation by cisplatin (CDDP) was repressed by YAP∆Cs. 
Luciferase assays were performed with MCF-7 cells 24 h after transfection of a p21/WAF1 reporter plasmid containing the p73 consensus cis-element and 
a YAP∆C expression vector (left). 25 μM CDDP was added 2 h after transfection. CDDP increased the transcription level to about threefold. Expression of 
YAP∆C isoforms (ins13, ins25, and ins61) remarkably repressed transcriptional activation by CDDP. FL-YAP (YAP) did not enhance the transcriptional activa-
tion, suggesting that endogenous YAP function was saturated. The expression of YAPs was checked simultaneously (right). n = 6. (B) YAP∆Cs suppressed NEURON DEATH BY TRANSCRIPTIONAL REPRESSION • HOSHINO ET AL.  597
in vivo, we analyzed p73 activation with brain samples of  human 
HD patients. Western blotting with human brain samples sug-
gested higher levels of p73 phosphorylation in HD brains than 
in control brains (Fig. 7 E).
Correspondingly, immunohistochemical analysis revealed 
an increase of phosphorylated p73 in striatal neurons of mutant 
Htt transgenic mice (R6/2) at 4 wk (Fig. 8, middle). It is note-
worthy that antiphosphorylated p73 antibody stained both the 
nucleus and cytoplasm of striatal neurons in R6/2 mice (Fig. 8, 
middle), although anti-p73 antibody detecting both nonphos-
phorylated and phosphorylated p73 proteins (full-length and 
NH2-terminus deletion forms) dominantly stained the cytoplasm 
(Fig. 8, left). On the other hand, YAP∆Cs were expressed in 
striatal neurons of both normal and R6/2 transgenic mice, 
whereas the signal was relatively stronger in transgenic mice 
(Fig. 8, right).
Furthermore, phosphorylation of p73 was detected in stri-
atal neurons of human HD patients (Fig. 9 A), suggesting that 
p73 is activated in human HD pathology. In this experiment 
(Fig. 9 B), because we used the antibody detecting full-length 
p73 but not ∆Np73, the full-length form of p73 was considered 
to be phosphorylated (Fig. 9 B, top). YAP∆Cs were shown to 
exist in striatal neurons of human HD patients by a specifi  c an-
tibody (Fig. 9 A, bottom right) and to be colocalized with acti-
vated p73 in striatal neurons (Fig. 9 B, bottom). It is important 
to note that phosphorylated p73 and YAP∆Cs were at very low 
levels in control human brains (Fig. 9 A, top). Collectively, 
these results suggest the possibility that p73 and YAP∆Cs 
might be involved in the HD pathology.
YAP𝖫C isoforms attenuate Htt-induced 
neurodegeneration of Drosophila
Finally, we examined the in vivo effect of YAP∆Cs on Htt-
  induced neurodegeneration in Drosophila models (Jackson 
et al., 1998). We generated more than three transgenic fl  y lines 
of human YAP∆Cs. In the transgenic fl  ies, the expression of 
YAP∆C protein was triggered by GMR-GAL4 that directs ex-
pression in the developing and adult eyes. To analyze the effects 
on photoreceptor neuron degeneration and/or the characteristic 
eye phenotype induced by the expression of human Htt120Q, 
we compared eye phenotypes between the F1 sibling fl  ies at 
10 d directly under the microscopy or by toluidine blue stain-
ing of 2-μm sections of epon-embedded eye tissues. Ommatidia 
structure and photoreceptor neurons were severely disrupted in 
GMR-Htt120Q/GMR-GAL4 double-transgenic fl  ies (BL8533; 
Jackson et al., 1998), whereas the expression of YAP∆C with 
a 61-nt insert (YAP∆C61) markedly preserved structure in 
triple-transgenic fl  ies  (GMR-Htt120Q/GMR-GAL4/UAS-
YAP∆C61; Fig. 10 A). Expression levels of YAP∆C61 and 
Htt120Q were checked in the same fl  y in parallel (Fig. 10 B). 
Quantitative analysis of rhabdomere numbers per ommatidium 
in four independent transgenic fl  y lines supported the repression 
of neurodegeneration by YAP∆C61 (Fig. 10 C). We observed 
similar improvement of neurodegeneration in other YAP∆C 
transgenic Drosophila fl  ies (not depicted). Collectively, these in 
vivo data further suggest the possibility that YAP∆C isoforms 
might play a protective role against the toxicity of mutant Htt 
in HD pathology.
Discussion
In this study, we report atypical neuronal death induced by tran-
scriptional repression (TRIAD). Transcriptional repression by 
Pol II–specifi  c inhibitors leads to a very slow atypical neuronal 
death whose progression is clearly different from the well-
known cell death prototypes. A morphological feature of TRIAD 
might be the vacuolization of ER, although it should be stressed 
that the majority of neurons (>90%) do not show remarkable 
morphological changes. These fi  ndings might be relevant to the 
roles of transcriptional disturbance in HD disease (for review 
see Gusella and MacDonald, 2000; Zoghbi and Orr, 2000; Ross, 
2002; Taylor et al., 2002; Bates, 2003; Okazawa, 2003; Sugars 
and Rubinsztein, 2003). In addition, the lengthy progression of 
TRIAD might cast light on the basic question of why neurons 
stay alive under neurodegeneration for a long period.
To the best of our knowledge, there are a few atypical cell 
deaths that might be partially analogous to TRIAD. One is a 
lengthy cell death of Dictyostelium discoideum during sorocarp 
formation, in which dying cells show cytoplasmic vacuolization 
(Cornillon et al., 1994). The second, termed paraptosis, is in-
duced by the overexpression of the intracellular domain of insu-
linlike growth factor I (IGF-I) receptor in 293T cells (Sperandio, 
et al., 2000). Paraptosis is characterized by vacuolization of the 
ER but no nuclear fragmentation, cellular blebbing, or apoptotic 
body formation (Sperandio, et al., 2000). These two atypical 
cell deaths might share molecular pathways (Wyllie and Gold-
stein, 2001). Although TRIAD shows a related   morphological 
change, TRIAD is clearly different from paraptosis, as the latter 
is inhibited by both actinomycin D and cycloheximide (Sperandio, 
et al., 2000). Another point that distinguishes TRIAD from 
paraptosis is the cell death stimulus. Paraptosis was reported 
only in ectopic expression of truncated IGF-I receptor in 
CDDP-induced apoptosis of MCF-7 cells. 25 μM CDDP was added to the medium 24 h after infection of adenovirus vectors, and cell death assay was per-
formed with annexin-V (Tagawa et al., 2004) in six wells after another 16 h. Adenovirus expression vectors are abbreviated as follows: AxCA, empty 
  adenovirus vector AxCAwt; YAP, AxCAYAP-FL; ins13, AxCAins13; ins25, AxCAins25; and ins61, AxCAins61. Right panel shows the expression of YAP 
  insert forms in cortical neurons. (C) YAP∆Cs suppressed TRIAD of cortical neurons. 24 h after infection of adenovirus vectors of YAP isoforms, 25 μg/ml AMA 
was added. Cell death was assayed with annexin-V (six wells) at 4 d. Right panel shows expression of YAP∆Cs in cortical neurons. (D) YAP∆C suppression 
by siRNA speciﬁ  c to a YAP∆C common sequence (siYAP∆) enhanced AMA-induced TRIAD of cortical neurons, supporting the idea that YAP∆Cs repress 
TRIAD of cortical neurons. Right panel shows speciﬁ  c repression of YAP∆Cs by siYAP∆. sc, siRNA of a scrambled sequence. 0.5 μg/well siRNA was trans-
fected into cortical neurons (2 × 10
4 cells/well of 24-well dish), and 25 μM AMA was added to the medium 12 h later. Cell death was quantiﬁ  ed by trypan 
blue staining in six wells at 4 d. (right) Bottom numbers represent relative intensities of the endogenous YAP∆C bands. (A–D) Asterisks indicate signiﬁ  cant 
differences from controls (P < 0.01, t test). Error bars represent SD. (E) p73 was activated in TRIAD of cortical neurons. Right panel shows fold increase of 
phosphorylated p73 by AMA treatment (25 μg/ml).JCB • VOLUME 172 • NUMBER 4 • 2006  598
  nonneuronal cells (Sperandio, et al., 2000). Furthermore, the 
role that we fi  nd for YAP in TRIAD has not been demonstrated 
in paraptosis or D. discoideum cell death. It is noteworthy that 
Degterev et al. (2005) has recently reported a new type of cell 
death—necroptosis. They showed that in the absence of intra-
cellular apoptotic signaling, extrinsic TNF stimulation triggers 
nonapoptotic cell death, showing necrotic morphology and 
  autophagy. Although rapamycin did not increase typical LC3-
negative vacuoles of TRIAD (Fig. S3) negating the autophagic 
component in TRIAD, we need to analyze carefully the rela-
tionship between TRIAD and necroptosis, including the view-
point of cell death speed.
It is also necessary to consider TRIAD with previous clas-
sifi  cations of cell death. Schweichel and Merker (1973) classi-
fi  ed three types of cell death. Type 1 was manifested as nuclear 
condensation and pyknosis, reduced cytoplasmic volume, and 
Figure 7.  Relevance of YAP𝖫C isoforms and p73 
to Htt-induced pathology. (A) YAP∆Cs repressed Htt-
induced cell death of cortical neurons. Primary corti-
cal neurons were coinfected by adenovirus vectors for 
mutant Htt (AxCAHtt111) and a YAP∆C (AxCAins13, 
AxCAins25, or AxCAins61). Cell death was assayed 
with trypan blue at 4 d. As a control, empty vector 
(AxCA) was used. Expression of mutant Htt was equiv-
alent among infections (not depicted). (B) Suppression 
of YAP∆Cs by YAP∆C sequence-speciﬁ  c siRNA   (siYAP∆) 
enhanced mutant Htt-induced cell death of cortical neu-
rons. 0.5 μg/well siRNA was transfected into primary 
cortical neurons (2 × 10
4 cells/well of 24-well dish) 
and infected with adenovirus vectors for mutant htt 
(AxCAHtt111) 12 h later. Cell death was quantiﬁ  ed 
by trypan blue in six wells at 4 d. (C) Phosphorylation 
of p73 was induced in cortical neurons expressing 
mutant Htt. Cortical neurons were harvested 48 h after 
infection of empty adenovirus vector (AxCA) or mutant 
Htt adenovirus vector (htt111). Immunoblotting was 
performed with anti-p73, antiphosphorylated p73, or 
anti-GAPDH (glyceraldehyde-3-phosphate dehydroge-
nase) anti  body (left). Relative values of phosphorylated 
p73 to total p73 were compared between AxCA-
  infected and AxCAHtt111-infected neurons (right). 
(D) Suppression of p73 by siRNA repressed Htt-induced 
cell death of cortical neurons (left). siRNA transfection 
and AxCAHtt111 infection were performed similarly 
to that in B. sip73, siRNA of p73; sc, siRNA of a 
scrambled sequence; Mock, mock treatment without 
siRNA. Cell death was quantiﬁ  ed by trypan blue stain-
ing in four independent wells at 4 d after infection. 
Right panel shows expression of p73 and GAPDH at 
the time point of infection of AxCAHtt111 and indi-
cates suppression of p73 by siRNA. (A, B, and D) 
Asterisks indicate signiﬁ  cant reduction of cell death in 
four independent assays (P < 0.01, t test). Error bars 
represent SD. (E) p73 phosphorylation was enhanced 
in the brain of human HD patients. Cerebral cortex 
tissues of three HD patients (lanes 4–6) and three 
  controls (lanes 1–3) were analyzed similarly (left). 
Relative values of phosphorylated p73 to total p73 
were calculated (right).NEURON DEATH BY TRANSCRIPTIONAL REPRESSION • HOSHINO ET AL.  599
late cell fragmentation/phagocytosis. Type 2 was an autophagic 
vacuolization in the cytoplasm, and type 3 was described as cy-
toplasmic cell death in which general organelle breakdown was 
apparent. Type 1 is apoptosis, and types 2 and 3 were necrotic 
(Schweichel and Merker, 1973). In 1990, Peter Clarke redefi  ned 
an earlier model of cell death developed by Schweichel and 
Merker (Clarke, 1990). Clarke’s modifi  cation was to expand the 
forms of cytoplasmic cell death into types 3A and 3B. 3A is a 
nonlysosomal breakdown, and 3B is cytoplasmic (Clarke, 
1990). Cells undergoing the 3A type of cell death show an ini-
tial swelling of cytoplasmic organelles and the generation of 
vacuoles that eventually fuse with the extracellular space. 
A breakup of cell structure without autophagic or heterophagic 
activity occurs. In type 3B death, which is also known as the cy-
toplasmic form of cell death, swollen organelles (dilated peri-
nuclear space, ER, and Golgi apparatus) are apparent as well as 
vacuoles. The cell membrane retracts, and the nucleus becomes 
karyolytic/edematous. Heterophagic elimination can occur. 
Type 3B has also been termed paraptosis/oncosis. Among these, 
TRIAD is close to type 3B. However, in addition to the afore-
mentioned reason, TRIAD seems to be different from type 3B 
because vacuolization of ER is far more remarkable than mor-
phological changes of other organelles in TRIAD.
In HD models, several studies have reported atypical cell 
death with cytoplasmic vacuolization. Sapp et al. (1997) re-
ported that mutant Htt accumulates in punctate structures mim-
icking endosomal–lysosomal organelles of affected HD neurons. 
They further showed by extensive analyses, including immuno-
electron microscopy, that mutant Htt appears in autophago-
somes (Kegel et al., 2000). Other studies also pointed out the 
possible involvement of autophagy in the HD disease pathology 
(Nagata et al., 2004; Ravikumar et al., 2004; Iwata et al., 2005). 
Meanwhile, Hirabayashi et al. (2001) isolated VCP (valosin-
containing protein)/p97, a member of the AAA+ family of 
ATPase proteins, as a HD-interacting protein. The expression of 
the mutant form of VCP leads to cytoplasmic vacuolization, 
which might be homologous to vacuoles in TRIAD because 
they were fused to ER (Hirabayashi et al., 2001). Collectively, 
although our results so far seem to negate the identity of the 
TRIAD vacuoles to autophagosomes, we cannot exclude 
the possibility that they might share certain characteristics with 
the vacuoles reported in HD models.
As for the molecular pathway of TRIAD, YAP∆Cs and 
p73 might modify the process. Up- or down-regulation of 
YAP∆Cs suppresses or enhances TRIAD in cortical neurons, 
respectively (Fig. 6, C and D). Together with evidence that 
AMA treatment increases active p73 in neurons (Fig. 6 E) and 
that YAP∆Cs remain during TRIAD of cortical neurons (Fig. 
4 G), these data suggest that p73-mediated cell death signaling 
might be attenuated by YAP∆Cs in TRIAD. Consistently, the 
percentage of morphologically changed neurons (vacuole-
  possessing neurons) was very low. It might be a reason why 
TRIAD does not progress rapidly like apoptosis.
p73 was activated in human and mouse HD pathology in 
vivo (Figs. 8 and 9). YAP∆C isoforms were coexpressed in af-
fected neurons of human HD patients (Fig. 9). Repression of 
p73 and expression of YAP∆Cs attenuated Htt-induced neuro-
nal cell death of primary neurons (Fig. 7, A and D), whereas 
YAP∆C repression enhanced the neuronal cell death (Fig. 7 B). 
Furthermore, YAP∆C isoforms suppressed neurodegeneration 
of photoreceptor cells of Drosophila in vivo (Fig. 10). These 
fi  ndings suggest that YAP∆Cs and p73 might be relevant to the 
HD pathology.
p53 has been implicated in the HD pathology because p53 
coaggregates with mutant Htt (Steffan et al., 2000). Bae et al. 
(2005) recently reported that mutant Htt interacts with, 
Figure 8.  YAP𝖫C and phosphorylated p73 
are expressed in striatal neurons of Htt trans-
genic mice. Immunohistochemical analyses of 
mutant Htt transgenic (R6/2) and sibling con-
trol mice were performed at 4 wk with anti-
p73 (full-length form), antiphosphorylated 
p73, or anti-YAP∆C antibodies. Arrows indi-
cate immunoreactive striatal neurons. Expres-
sion of phosphorylated p73 was increased in 
R6/2 transgenic mice (middle), whereas the 
total amount of p73 was similar in transgenic 
and control mice (left). Immunoreactivities of 
YAP∆C were slightly increased in transgenic 
mice (right).JCB • VOLUME 172 • NUMBER 4 • 2006  600
  translocates, and activates p53. They also showed that mating 
mutant Htt transgenic mice with p53-null mice ameliorates neu-
rological symptoms by mutant Htt (Bae et al., 2005). These re-
sults suggest that p53 activation promotes the HD pathology. 
Because p73 and p53 belong to the same family of transcription 
factors recognizing a similar consensus sequence on genomic 
DNA (for review see Irwin and Miller, 2004), the common cas-
cade shared by the two factors should be investigated in the HD 
pathology. For instance, upstream signals activating these two 
factors and target gene activation by these transcription factors 
in the HD pathology should be analyzed in the future. On the 
other hand, because p53 is suggested to have a direct effect on 
mitochondria (Mihara et al., 2003), it might be necessary to test 
whether p73 also plays a similar role. 
It is important to note that hyperactive p73 could trigger 
vacuolar changes of ER in nonneuronal cells (Terrinoni et al., 
2004). If this is true, the vacuole formation in TRIAD might be 
triggered by activated p73. In this case, although ER stress 
could be induced by mutant polyQ protein (Kouroku et al., 
2002; Nishitoh et al., 2002), ER stress might also be evoked 
by a signal from the nucleus in parallel. Investigation on the 
possible connection between the nucleus and ER might 
contribute to understanding the polyQ pathology. The hypothet-
ical pathway should be examined and elucidated in the future. 
In summary, our results present a novel model of cell death that 
might cast more light on the HD pathology.
Materials and methods
Primary neuron culture
Cerebral cortex tissues isolated from E17 Wistar rat embryos and cerebel-
lar tissues isolated from P7 Wistar rat pups were minced (with razors) and 
treated with 0.25% trypsin (Invitrogen) in PBS, pH 7.5, at 37°C for 20 min 
with gentle shaking every 5 min. After stopping the reaction with DME con-
taining 50% FBS, DNase I (Boehringer) was added to the solution at a ﬁ  nal 
concentration of 100 μg/ml, and tissues dissociated gently by pipetting 
with blue tips. Cells ﬁ  ltered by nylon mesh (pore size of 70 mm; Falcon; BD 
Biosciences) were collected by centrifugation, resuspended in DME supple-
mented with 20 mM glucose, 16 mM sodium bicarbonate, 4 mM gluta-
mine, 25 μg/ml gentamicin, and 10% FBS, and plated on 24-well dishes 
(Corning) coated by poly-L-lysine (Sigma-Aldrich) at 3 × 10
5 cells/well. 
12 h after plating, cytosine arabinoside was added to the culture medium 
at 4 M of ﬁ  nal concentration to prevent the growth of glial cells. Cerebellar 
neurons were cultured at high potassium (25 mM) ordinarily but were cul-
tured at 5.4 mM potassium to induce apoptosis. Cortical neurons were cul-
tured at low potassium condition (5.4 mM). Necrosis of cortical neurons 
Figure 9.  YAP𝖫C and phosphorylated p73 are coex-
pressed in striatal neurons of human HD brain. (A) Immuno-
reactivities of phosphorylated p73 and YAP∆C isoforms 
were increased in striatal neurons of HD patients (arrows). 
Postmortem brain tissues, including the caudate nucleus, 
were prepared from three HD patients and three controls. 
(B) Double staining with anti-p73 rabbit polyclonal anti-
body speciﬁ  c for full-length p73 but not reactive to ∆Np73 
(H-79; 1:500; Santa Cruz Biotechnology, Inc.) and with 
antiphospho-p73 rabbit polyclonal antibody (1:500; Cell 
Signaling) showed colocalization of the two signals in 
most striatal neurons of HD patients (top, white arrows). 
It   suggests that the full-length p73 is phosphorylated in 
striatal neurons. Bottom panels show that YAP∆C isoforms 
were colocalized with phosphorylated p73 in striatal neu-
rons (bottom, white arrows). However, a minor portion of 
neurons expresses only p73 (red arrows).NEURON DEATH BY TRANSCRIPTIONAL REPRESSION • HOSHINO ET AL.  601
was induced by the freeze and thaw treatment. To induce TRIAD, AMA 
(Sigma-Aldrich) was added to the medium at a ﬁ  nal concentration of 10 or 
25 μg/ml, except for dose–response survival experiments in which the 
  ﬁ   nal concentration was 10–250 μg/ml. Actinomycin D (Sigma-Aldrich) 
was added to the medium at 0.1, 0.5, or 2.5 μg/ml.
Cell death assay
Cell death assays were performed either by trypan blue dye exclusion 
  assay or MTT assay as described in each ﬁ  gure legend. For trypan blue 
assay, cells were incubated for 5 min in 0.4% trypan blue (Invitrogen). 
Blue-stained (nonviable) and nonstained (viable) cells were counted 
(at least 2,000 cells for each condition) in 10–20 visual ﬁ  elds randomly 
selected at 100× from each of three dishes, as described previously 
(Tagawa et al., 2004). MTT assay was performed with MTT cell prolifera-
tion/viability assay (R&D Systems) according to the commercial protocol. 
At each time point, the value of drug-treated cells was corrected to the 
value of nontreated cells as 100%.
Acquisition and processing of microscopic images
Regarding electron microscopic observation, cells were washed with PBS 
three times, ﬁ  xed in 2.5% glutaraldehyde/0.1 M phosphate buffer, and 
treated with 1% OsO4/0.1 M phosphate buffer for 2 h. Fixed cells were 
dehydrated through a graded ethanol series and embedded in epoxy 
resin. Ultrathin sections were stained with uranyl acetate and lead citrate 
and examined with a transmission electron microscope (H-9000; Hitachi) at 
24°C (5,000–50,000×). Numerical aperture of the objective lens was 4, 
and the imaging medium was air. Data acquisition was performed by elec-
tron microscope ﬁ  lm.
As for immunocytochemistry, stained cells were observed with a mi-
croscope (IX-71; Olympus) at RT (20 or 40×; NA 0.40 or 0.60, respec-
tively), and the imaging medium was air. Data acquisition was performed 
with a camera (C4742-95-12ERG; Hamamatsu), a controller (ORCA-ER; 
Hamamatsu), and A  Q  U  A  C  O  S  M  O  S   software (Hamamatsu). The ﬂ  uoro-
chromes will be described in each method.
Analysis of autophagy
24 h after transfection of pEGFP-LC3, HeLa cells were treated with 10 μg/ml 
AMA and observed by ﬂ  uorescence microscopy (Fig. 2). To further ana-
lyze the relationship between LC3-positive phagosomes and AMA-induced 
vacuoles, autophagy was induced by 200 ng/μl rapamycin for 2 h 
(Sigma-Aldrich; for review see Klionsky and Emr, 2000). LC3-positive and 
-negative vacuoles were counted in the presence or absence of AMA. HeLa 
cells were transfected with pEGFP-LC3 by SuperFect (QIAGEN), collected 
36 h after transfection, and subjected to Western blot analysis. Anti-EGFP 
polyclonal antibody (BD Living Colors) and anti-LC3 antibody were used at 
dilutions of 1:1,000 and 1:2,000, respectively. pEGFP-LC3 and anti-LC3 
antibody were gifts from T. Yoshimori (National Institute of Genetics, 
Mishima, Japan) and N. Mizushima (Tokyo Metropolitan Institute for Medical 
Science, Tokyo, Japan).
Identiﬁ  cation of AMA-induced vacuolization
After treatment of AMA (Sigma-Aldrich) for 6 h, HeLa cells were washed 
with PBS and ﬁ  xed using 4% PFA for 15 min at RT. Cells were incubated for 
1 h at RT with the following primary antibodies: anti-CCO1 mouse mono-
clonal antibody (1:100; Invitrogen); anti-EEA1 mouse monoclonal antibody 
(1:100; Transduction Laboratories); anti-Golgi58k mouse monoclonal 
  antibody (1:100; Sigma-Aldrich); and anti-CD63 (1:100; Cymbus Biotech-
nology Ltd.). Secondary antibodies conjugated with AlexaFluor488 (Invit-
rogen) were used at a dilution of 1:1,000 and hybridized for 30 min at RT. 
HeLa cells were transfected by pEGFP-LC3 (a gift of N. Mizushima and 
Figure 10.  YAP𝖫C represses neurodegen-
eration of Drosophila ommatidia. (A) Morpho-
logical analyses of photoreceptor cells in cross 
sections of Drosophila ommatidia. In wild type 
(WT), a single ommatidium possesses seven 
rhabdomeres aligned regularly, whereas om-
matidia structure and photoreceptor neurons 
were severely destructed in Htt120Q trans-
genic ﬂ  ies (GMR-HD120Q/+;GMR-GAL4/+). 
Expression of YAPins61 remarkably improved 
the structural anomalies (GMR-HD120Q/UAS-
YA∆61;GMR-GAL4/+). (B) Expression levels 
of Htt120Q and YAP∆C61 were examined 
by Western blot analysis in the same ﬂ  y  as 
shown in Fig. 7 A. (C) Quantitative analysis of 
rhabdomere numbers per ommatidium in WT, 
Htt120Q transgenic ﬂ  ies  (GMR-HD120Q/+;
GMR-GAL4/+), and a representative line 
of transgenic ﬂ  ies  (GMR-HD120Q/UAS-
YAP∆61;GMR-GAL4/+) supported the re-
pression of neurodegeneration by YAP∆C61. 
More than 30 ommatidia were analyzed in 
three ﬂ   ies from a line. The results with other 
three lines of transgenic ﬂ  ies (GMR-HD120Q/
UAS-YAP∆61;GMR-GAL4/+) were basically 
similar (not depicted).JCB • VOLUME 172 • NUMBER 4 • 2006  602
T. Yoshimori; Kabeya et al., 2000) or pECFP-ER (BD Biosciences) using 
Superfect (QIAGEN) according to the manufacturer’s instructions.
Western blot analyses of caspase-3, -7, and -12
Primary neurons were treated with 25 μg/ml AMA as indicated and were 
dissolved in 62.5 mM Tris-HCl, pH 6.8, 2% (wt/vol) SDS, 2.5% (vol/vol) 
2-mercaptoethanol, 5% (vol/vol) glycerin, and 0.0025% (wt/vol) bromo-
phenol blue on culture dishes. Positive controls for caspase-3 and -7 were 
prepared from HeLa cells treated with 1 μM staurosporin (Sigma-Aldrich) 
for 5 h. For a caspase-12 control, HeLa cells were treated with 20 μM 
A23187 (Calbiochem) for 24 h. Primary and secondary antibodies were 
diluted as follows: anticaspase-3 polyclonal rabbit antibody (Cell Sig-
naling) at 1:1,000; anticaspase-6 polyclonal antibody (Cell Signaling) 
at 1:500; anticaspase-7 polyclonal antibody (Cell Signaling) at 1:500; 
anticaspase-12 polyclonal antibody (14F7; Sigma-Aldrich) at 1:1,000; 
HRP-conjugated anti–rabbit IgG (GE Healthcare) at 1:3,000; and HRP-
conjugated anti–rat IgG (Sigma-Aldrich) at 1:20,000.
Cytochrome c release
10
7 primary cortical neurons were treated with 10 μg/ml AMA as indi-
cated (Fig. 3 C). As a positive control, the same amount of primary cortical 
neurons were treated with 1 μM staurosporin (Sigma-Aldrich) for 8 h. The 
cells were washed twice with ice-cold PBS on the dish, collected, and sus-
pended in 500 μl of ice-cold buffer (20 mM Hepes, pH 7.4, 10 mM KCl, 
1.5 mM MgCl2, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, and 250 mM su-
crose) and disrupted by moderate strokes in a homogenizer. The homoge-
nate was centrifuged twice at 1,300 g for 5 min to remove nuclei, unbroken 
cells, and large membrane fragments. From the supernatant, mitochondria 
were isolated by further centrifugation at 17,000 g and 4°C for 15 min. 
Pellets were dissolved in the sample buffer described above, separated by 
15% SDS-PAGE, blotted to polyvinylidene diﬂ   uoride membranes (Fine 
Trap; Nihon Eido), incubated with cytochrome c monoclonal antibody 
(1:1,000; Santa Cruz Biotechnology, Inc.), and subjected to HRP-coupled 
detection. The supernatant of the ﬁ  nal centrifugation was used as a cyto-
solic fraction.
RNA probes for microarray analyses
Cells in culture dishes are harvested in TRIzol reagent (Invitrogen) after 
rinsing with PBS twice, and total RNA was prepared according to the 
manufacturer’s protocol. Labeling and ampliﬁ   cation of RNA was per-
formed using the Agilent Fluorescent Linear Ampliﬁ  cation Kit (G2554A; 
Agilent Technologies) according to the manufacturer’s protocol. First, 
  double-stranded cDNAs with a T7 promoter were synthesized from 2 μg 
of total RNA by Moloney murine leukemia virus reverse transcriptase using 
an oligonucleotide dT-primer, which contains the T7 promoter sequence, 
and random hexamers (40°C for 4 h). Then, using these double-stranded 
  cDNAs as templates, cRNA was synthesized by T7 RNA polymerase using 
Cy3- or Cy5-labeled CTP (40°C for 1 h). cRNAs from AMA-treated cortical 
neurons, AMA-treated cerebellar neurons, or low potassium–  exposed cer-
ebellar neurons were labeled with Cy3 or Cy5. Synthesized cRNA was 
precipitated with lithium chloride, ethanol rinsed, and dissolved in nucle-
ase-free water. To check the quality of cRNA, OD260, OD280, A552 
(for Cy3), and A650 (for Cy5) measurements were taken. Then, OD260/
OD280, ampliﬁ  cation rates and dye incorporation rates (pmol/μg RNA) 
of cRNA were calculated. Using these criteria, we found that our sam-
ples were of high quality (OD260/OD280,  <2.0; ampliﬁ  cation  rate, 
<400; Cy3 incorporation, <15 [pmol/μg RNA]; and Cy5 incorpora-
tion, <12 [pmol/μg RNA]).
Microarray analysis
Hybridization procedures were performed using the In situ Hybridization 
Kit Plus (5184–3568; Agilent Technologies) according to the  manufacturer’s 
protocol. First, Cy3- and Cy5-labeled cRNAs (1 μg each) were mixed and 
incubated with fragmentation buffer (Agilent Technologies) at 60°C for 
30 min. Mouse Development Oligo Microarray (G4120A; Agilent Tech-
nologies), which contains 20,371 60-mer oligonucleotides from mouse 
cDNA, was hybridized with fragmented cRNA targets at 60°C for 17 h us-
ing CHBIO (Hitachi). Hybridized microarrays were rinsed twice and dried 
by spraying N2 gas (99.999%) using a ﬁ  lter-equipped air gun (mycrolis 
KK; Nihon).
Fluorescent signals were read using a microarray scanner (CRBIO 
IIe; Hitachi). Data were analyzed using analysis software (DNASIS array; 
Hitachi). In brief, data either from control spots or from spots containing 
high intensities of artiﬁ  cial signals were removed. Then, the signal intensity 
of each spot was normalized to equalize total signal intensity. Normalized 
signal intensity of each spot was plotted on a scatter plot with Cy3 ﬂ  uores-
cence on the y axis and Cy5 ﬂ  uorescence on the x axis. The ratio of Cy3/
Cy5 ﬂ  uorescence was calculated, and genes with outstanding Cy3/Cy5 
ratios of >2.0 or <0.5 were listed.
To conﬁ   rm the results, we also used a rat cDNA microarray 
(G4105A; Agilent Technologies) on which cDNAs (mean length of 500 
bases) derived from 14,811 genes were spotted. cDNA probes were la-
beled by the Direct Label Kit (G2557A; Agilent Technologies) with an 
  oligonucleotide dT primer according to the manufacturer’s protocol. The 
chips were hybridized at 65°C for 17 h and washed with 0.5× SSC and 
0.01% SDS for 5 min at RT and with 0.06× SSC for 2 min at RT.
PCR cloning
RT-PCR cloning of YAP was conducted with cDNA reverse transcribed from 
1 mg of total RNA prepared from rat cortical neurons by using the RNA LA 
PCR Kit (Takara) and primers F (5′-G  G  A  A  T  T  C  T  A  T  G  G  A  G  C  C  C  G  C  G  C  A  A  -3′) 
and R (5′-A  C  G  C  G  T  C  G  A  C  C  T  A  T  A  A  C  C  A  C  G  T  G  A  G  -3′). PCR ampliﬁ  cation 
was performed for 35 cycles (94°C for 30 s, 52°C for 30 s, and 72°C for 
90 s). The resultant cDNAs were subcloned between EcoRI and SalI sites 
of pBluescriptII SK+. Nucleotide sequences were determined by using 
M13 or synthesized internal primers and the ABI PRISM BigDye Terminator 
Cycle Sequencing Kit version 3.1 (Applied Biosystems) and ABI PRISM 
310 DNA Sequencer (Applied Biosystems). pBluescript plasmids contain-
ing 13-, 25- and 61-nt insert forms of YAP were named pBSins13, 
pBSins25, and pBSins61, respectively. The cDNA of each YAP insert was 
subcloned into pCI neo (Promega) and denoted pCIins13, pCIins25, and 
pCIins61, respectively.
Luciferase assay
5 × 10
6 cells MCF-7 cells were transiently transfected with 5 μg of pGL3-
Bax-Luc (Strano et al., 2002) with pCI–FL-YAP, -YAP∆C (pCIins13, pCIins25, 
and pCIins61), or control pCI-neo using LipofectAMINE 2000 (Invitrogen) 
according to the protocol described previously (Basu et al., 2003).
Western blot analysis
Cells were resuspended in 62.5 mM Tris-HCl, pH 6.8, 2% (wt/vol) SDS, 
2.5% (vol/vol) 2-mercaptoethanol, 5% (vol/vol) glycerin, and 0.0025% 
(wt/vol) bromophenol blue on culture dishes. Cell lysates prepared from 
wells containing either 3.3 × 10
4 HeLa cells or 1.0 × 10
5 primary neurons 
were subject to SDS-PAGE gels, transferred onto polyvinylidene diﬂ  uoride 
membranes (Fine Trap; Nihon Eido), incubated with each primary antibody 
for 1 h and the corresponding HRP-conjugated secondary antibody for 
30 min, and visualized using the ECL Western Blotting Detection System 
(GE Healthcare). The dilution conditions for primary and secondary anti-
bodies were as follows: anti-YAP polyclonal rabbit antibody (H-125; Santa 
Cruz Biotechnology, Inc.) at 1:1,000; anti-GAPDH mouse monoclonal anti-
body (Chemicon) at 1:100,000; HRP-conjugated anti–mouse IgG (GE 
Healthcare) at 1:5,000; and HRP-conjugated anti–rabbit IgG (GE Health-
care) at 1:3,000. Anti-YAP∆C rabbit polyclonal antibody was raised against 
the common COOH-terminal peptide (S  V  F  S  R  D  D  S  G  I  E  D  N  D  N  Q  ) by immuniz-
ing rabbits and was used for Western blotting at a 1:1,000 dilution.
Adenovirus vector construction
The replication-defective adenovirus vectors were constructed by using the 
Adenovirus Expression Vector Kit (Takara) according to the manufacturer’s 
instructions. In brief, cDNAs of YAP isoforms were digested with EcoRI 
and SalI from pBSYAP-FL (containing rat FL-YAP), pBSins13, pBSins25, and 
pBSins61. Ends were blunted using the blunting high kit (Toyobo), and 
each insert was subcloned into the SwaI site of the pAxCAwt cosmid 
  (Takara). The resultant cosmids were transfected into 293T cells by the 
  calcium-phosphate method with digested DNA of adenovirus and the me-
dium containing dead cells recovered as the virus solution. After two or 
three rounds of ampliﬁ  cation  (5  × 10
8 and  5 × 10
9 plaque-forming 
units/ml), clonality was checked by restriction with endonucleases and 
PCR. We designated the adenovirus vectors AxCAYAP-FL, AxCAins13, Ax-
CAins25, and AxCAins61. The vectors were used for infection of HeLa 
cells and primary neurons at a multiplicity of infection (MOI) of 100. Pre-
liminary examination of the efﬁ  ciency of protein expression and toxicity of 
adenovirus was performed by infecting primary neurons with a vector for 
EGFP and a mock vector at multiple MOI, respectively. More than 90% of 
the neurons expressed EGFP at an MOI of 100. The difference in cell death 
percentage between noninfected and mock-infected neurons estimated by 
trypan blue staining was <3% when the MOI did not exceed 500.
Northern blotting
10 μg of total RNA from primary culture neurons was subjected to elec-
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capillary blotted to Hybond-N (GE Healthcare) and ﬁ  xed by UV cross-linking 
(120,000 μJ/cm
2). Full-length cDNA of ins61 was digested from pB-
Sins61, puriﬁ   ed from gel, and radiolabeled using α-[
32P]dCTP (GE 
Healthcare) and a random primer DNA labeling kit (Takara). 
32P-labeled 
probes were hybridized to nylon membrane at 60°C overnight with shak-
ing. Hybridized membrane was rinsed with 1× SSC, 0.1% SDS at 50°C 
for 20 min twice, and with 0.1× SSC and 0.1% SDS at 60°C for 20 min 
twice. The membrane was then exposed to X-ray ﬁ  lm for an appropriate 
time at −80°C.
RNA interference
Cells were transfected with siRNA oligonucleotides by RNAiFect (QIAGEN) 
according to the manufacturer’s instructions. 2.5 × 10
4 cells in six-well 
dishes were infected at 0.5 μg siRNA/well 24 h after plating. 24 h after 
infection, AMA was added to a ﬁ  nal concentration of 10 μg/m. The cell 
death assay was performed after another 24 h. Sequences of siRNAs of 
YAP and p73 were the same as those published previously (Basu et al., 
2003). Sequences of the YAP∆C isoform-speciﬁ  c siRNAs were 5′-r(A  C  C  G-
T  C  A  G  A  G  C  G  G  G  A  A  T  T  A  G  C  T  C  )d(TT)-3′ and 5′-r(G  A  G  C  T  A  A  T  T  C  C  C  G  C  T  C  T-
G  A  C  G  G  T  )d(TT)-3′, corresponding to the common exon among three 
YAP∆C isoforms.
Analysis of p73 phosphorylation
HeLa cells and cortical neurons were treated with 10 μg/ml AMA for 6 h 
and 2 d, respectively. For the Htt experiments, HeLa cells and primary corti-
cal neurons were harvested 2 d after infection. HeLa cells or primary corti-
cal neurons were dissolved in TNE buffer (10 mM Tris-HCl, pH 7.8, 1% 
NP-40, 0.15 M NaCl, 1 mM EDTA, 10 μg/ml aprotinin, 1 mM PMSF, 
1 mM Na3VO4, and 1 mM NaF), and the supernatant was collected after 
centrifugation. Nonspeciﬁ  c binding proteins were removed by preincuba-
tion with protein G–Sepharose beads (GE Healthcare), and anti-p73 goat 
polyclonal antibody (S-20; Santa Cruz Biotechnology, Inc.) was added to 
the supernatant at 1:200. The mixture was incubated overnight at 4°C and 
precipitated by protein G–Sepharose beads for 1 h at 4°C. After washing 
ﬁ  ve times with TNE, the precipitate was boiled in 2× loading buffer and 
subjected to Western blot analysis. The ﬁ  lter was blotted with the anti-p73 
goat polyclonal antibody (S-20; 1:1,000; Santa Cruz Biotechnology, Inc.) 
or antiphosphorylated p73 rabbit polyclonal antibodies (1:1,000; Cell 
Signaling) followed by HRP-coupled detection. For analysis of p73 phos-
phorylation in human brain, each sample of striatum was homogenized in 
20× vol TNE and subjected to the detection of p73 phosphorylation by 
Western blotting and immunohistochemistry.
Immunohistochemistry of transgenic mouse brains
Brain tissues were prepared from 4-wk-old R6/2 transgenic mice and the 
littermates. After deparafﬁ  nization and rehydration, the sections were incu-
bated sequentially with 3% hydrogen peroxide for 30 min to inhibit endog-
enous peroxidase, 1.5% normal goat serum in PBS for 1 h at RT, and either 
a rabbit polyclonal antibody speciﬁ  c for full-length p73 that was raised 
against the NH2-terminal 80 amino acids of p73 (H-79; 1:100; Santa 
Cruz Biotechnology, Inc.), an antiphospho-p73 rabbit polyclonal antibody 
(1:50; Cell Signaling), or an anti-YAP∆C rabbit polyclonal antibody 
against the common COOH-terminal peptide (S  V  F  S  R  D  D  S  G  I  E  D  N  D  N  Q  ) of 
YAP∆C isoforms (1:100). These incubations were overnight at 4°C. The 
slides were incubated with anti–rabbit EnVision conjugates of secondary 
antibody (DakoCytomation) for 1 h at RT and visualized with DAB (Sigma-
Aldrich). The same protocol was applied for immunohistochemistry of hu-
man brain sections. For double staining, each section after the ﬁ  rst staining 
was agitated in stripping buffer (0.05 M glycine-HCl, pH 3.6) for 3 h at RT, 
hybridized with anti–glial ﬁ   brillary acidic protein polyclonal antibody 
(1:1,000; Chemicon) overnight at 4°C and with anti–rabbit EnVision con-
jugates of secondary antibody (DakoCytomation) for 1 h at RT, and 
  visualized with DAB (Sigma-Aldrich) containing NiCl2 6H2O.
Immunohistochemistry of human brain samples
Postmortem brain tissues were prepared from HD patients diagnosed by 
CAG repeat expansion. The parafﬁ  n-embedded section was deparafﬁ  n-
ized, rehydrated, and blocked with 5% skim milk in PBS for 30 min at RT. 
Single staining was performed as described in the previous section. For 
double staining, the section was incubated with anti-p73 rabbit polyclonal 
antibody speciﬁ  c for full-length p73 (H-79; 1:500; Santa Cruz Biotechnol-
ogy, Inc.) or with or an anti-YAP∆C rabbit polyclonal antibody overnight at 
4°C, washed with TNT (0.1% Tween 20–TBS) buffer twice, incubated with 
HRP-conjugated secondary antibody (1:3,000; GE Healthcare) for 1 h at 
RT, washed with TNT buffer twice, and visualized by incubation with FITC-
tyramide (1:200; PerkinElmer) for 10 min. The tyramide complex was 
stripped off by incubation with 0.05 M glycine-HCl, pH 3.6, for 3 h at RT. 
After complete stripping, antiphospho-p73 rabbit polyclonal antibody 
(1:500; Cell Signaling) was hybridized and visualized with Cy3- conjugated 
secondary antibody (1:1,000; Chemicon).
Drosophila genetics
Fly culture and mating were carried at 25 and 60% humidity. P(GMR-
GAL4) (BL8121) and P(GMR-HD120Q) (BL8533) (Jackson et al., 1998) 
were obtained from the Bloomington Stock Center. The UAS-YAPins13, 
25, and 61 transgenic ﬂ  ies were generated by cloning the correspond-
ing human cDNA into pUAST transformation vector and injecting the 
construct DNA into cantonized w(cs10) (Dura et al., 1993) by standard 
methods (Rubin and Spradling, 1982). Genotypes of the YAP transgenic 
ﬂ   ies were determined by mating them with double balancer ﬂ  ies,  and 
they were kept with a balancer gene before use. To analyze the effects of 
YAPins61 on photoreceptor neuron degeneration and/or the characteristic 
eye phenotype induced by the expression of human Htt 120Q, we com-
pared eye phenotypes between the F1 sibling ﬂ  ies (GMR-HD120Q/UAS-
YAP∆61;GMR-GAL4/+ vs. GMR-HD120Q/+; GMR-GAL4/+) directly 
under the microscopy VH5000 (Keyence) or by toluidine blue staining of 
2-μm sections of epon-embedded eye tissues.
Drosophila histology
For sections of ﬂ   y photoreceptor neurons, adult heads (0–10 d) were 
preﬁ   xed overnight in 2% formaldehyde and 2.5% glutaraldehyde in 
0.1 M phosphate buffer overnight at 4%, postﬁ  xed in 1% osmium at RT 
for 3 h followed by dehydration in ethanol and embedding in epon for 
vertical and transversal semi-thin sections (2 μm), and stained with tolu-
idine blue. At least ﬁ  ve individuals were examined in each ﬂ  y line and at 
each time point.
Online supplemental materials
Fig. S1 shows an MTT assay of TRIAD. Fig. S2 shows immunocytochemi-
cal analysis of TRIAD-associated vacuoles. Fig. S3 shows that TRIAD is 
neither autophagy nor apoptosis. Fig. S4 shows that actinomycin D also 
induced TRIAD. Fig. S5 shows transcriptome analysis of TRIAD. Online 
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200509132/DC1.
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